MedTrace Logo

Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic

NCT00159523 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 416

Last updated 2016-02-05

No results posted yet for this study

Summary

A probiotic (Lactobacillus rhamnosus GG) supplement to pregnant women the last four weeks of pregnancy and three months after birth is expected to give a 40% reduction in risk of atopic sensitisation and allergic disease at two years of age, compared to placebo.

Conditions

  • Asthma
  • Dermatitis, Atopic
  • Rhinitis, Allergic, Perennial

Interventions

DIETARY_SUPPLEMENT

Probiotic

BIOLOGICAL

placebo

Sponsors & Collaborators

  • Tine

    collaborator INDUSTRY

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Anne Katarina Cartfjord, Director · Faculty of Medicine, NTNU

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Weeks
Max Age
36 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00159523 on ClinicalTrials.gov